Impact Factor
2.97
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.62
442 total citations
h5-index
24
h5 depth signal
Cited share
60.4%
171 of 283
Total citations
442
Citation footprint
Metric signal
1.54
External metric anchor
Self-citation
4.5%
20 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
695
China
302
Japan
132
United Kingdom
110
Germany
68
Citing Fields of Research
Pharmacology & Toxicology
495
Cancer Drugs
221
Cardiology
139
Diabetes
114
Anesthetic & Pain Medicine
79
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,608
Articles tracked across the journal lifetime
Indexed publication set
283
171 cited publications
Last 12 months
130
10.8 publications/month
Open access share
43.1%
56 OA publications in the last year
Leading citing country
United States
695 citing publications
Leading citing field
Pharmacology & Toxicology
495 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v5n1, Jan-Feb 2016-
v5n1, Jan-Feb 2016- ; Selected citations only before this date
Research Focus & Classification
Indexed Subjects
Pharmacology & Toxicology
Issuing & Sponsoring Bodies
Contributor
American College of Clinical Pharmacology
Broad Categories
Drug Therapy
Pharmacology
Drug Delivery Systems
Diabetes
Urology
Cardiology
Cancer Drugs
HIV
Separation Techniques
MeSH Descriptors
Clinical Trials as Topic
Drug Evaluation
Drug Evaluation, Preclinical
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/cpdd.70112
Open DOI
Formulation‐Dependent Modulation of Ibuprofen Absorption Kinetics in Fixed‐Dose Combinations: An Exploratory Analysis of the Dissolution–Absorption Relationship
We conducted a pharmacokinetic study to compare two fixed‐dose combinations of ibuprofen/acetaminophen (IP‐TA and IP‐TB) with different formulation designs and excipient compositions, and explored how formulation differences influence ib...
02
03
DOI 10.1002/cpdd.70111
Open DOI
Pharmacokinetic Interaction Between Eperisone and Ojeok‐San in Healthy Subjects
Ojeok‐san is a traditional multiherbal formulation commonly prescribed for musculoskeletal symptoms in East Asian medicine. The concomitant use of herbal medicines and conventional pharmacotherapy is common in patients with musculoskelet...
04
DOI 10.1002/cpdd.70105
Open DOI
Fed–Fasted Differences in Clindamycin Hydrochloride Capsule Pharmacokinetics: A Pooled Analysis of Publicly Available China CDE Regulatory Summaries
We evaluated food‐associated differences in clindamycin hydrochloride capsule exposure by pooling publicly available regulatory bioequivalence (BE) summaries from the Center for Drug Evaluation of the National Medical Products Administra...
05
DOI 10.1002/cpdd.70106
Open DOI
Population Pharmacokinetics and Exposure–Response Analysis of Arpraziquantel Supporting Dose in Preschool‐Aged Children Infected with Schistosoma
Schistosomiasis is an acute and chronic parasitic disease that occurs mainly in sub‐Saharan and African countries and for which no treatment is available in preschool‐aged children (PSAC). An open‐label, Phase III study of arpraziquantel...
06
DOI 10.1002/cpdd.70110
Open DOI
Pharmacokinetic and Bioequivalence of Mirtazapine Orally Disintegrating Tablets: A Randomized, Crossover Study
The study aimed to assess the bioequivalence of a new generic orally disintegrating tablet (ODT) formulation containing mirtazapine 30 mg with the reference formulation, and to support biowaiver for an additional 15 mg strength. Fifty‐fi...
07
DOI 10.1002/cpdd.70104
Open DOI
Pharmacokinetic and Bioequivalence Evaluation of Febuxostat 40 mg Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions
The objective of the current study was to evaluate the rate and extent of absorption, and confirm the bioequivalence of a test formulation and a reference formulation of febuxostat 40 mg tablets in healthy Chinese subjects under both fas...
08
DOI 10.1002/cpdd.70107
Open DOI
Pharmacokinetics, Immunogenicity, and Safety of a Modified YTE Antibody in Healthy Adults
REGN17092, a fully human immunoglobulin (Ig) G1 antibody with M252Y/S254T/T256E (YTE) modification in the Fc portion, was assessed in a first‐in‐human study (ClinicalTrials.gov, NCT05923424). REGN17092 was designed to target the severe a...
09
DOI 10.1002/cpdd.70091
Open DOI
Systemic Bioavailability of Topical Diclofenac: Sodium 1% Versus Diethylamine 1.16% and the Effect of Heat or Exercise in a Randomized Cross‐Over Study
Diclofenac is a widely used topical nonsteroidal anti‐inflammatory drug (NSAID) for pain and inflammation. This study evaluated the relative bioavailability of diclofenac from diclofenac sodium (DS) gel 1% versus diclofenac diethylamine ...
10
DOI 10.1002/cpdd.70092
Open DOI
Pharmacokinetic and Pharmacodynamic Drug‐Drug Interactions Between Cofrogliptin and Metformin in Healthy Subjects: A Single‐Center, Single‐Arm, Phase I Study in China
This single‐center, single‐arm, Phase I study evaluated drug–drug interactions (DDIs) between cofrogliptin and metformin in healthy Chinese subjects. Twenty‐two subjects sequentially received metformin monotherapy (Days 1–4), cofroglipti...
Bibliographical & Catalog Notes
Mode of access: World Wide Web.
Official publication of the American College of Clinical Pharmacology.